Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages

Camila M aria Longo Machado, Luciana N ogueira Sousa Andrade, Verônica Rodrigues Teixeira, Fabrício Falconi Costa, Camila M orais Melo, Sofia N ascimento dos Santos, Suely Nonogaki, Fu-Tong Liu, Emerson S oares Bernardes, Anamaria A ranha Camargo, Roger Chammas

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

In order to study the role of galectin-3 in tumor angiogenesis associated with tumor-associated macrophages (TAM) and tumor parenchyma, the galectin-3 expression was reconstituted in Tm1 melanoma cell line that lacks this protein. Galectin-3-expressing cells (Tm1G3) and mock-vector transfected cells (Tm1N3) were injected into wild-type (WT) and galectin-3 knockout (KO) C57Bl/6 mice. Tumors originated from Tm1G3 were larger in tumor volume with enlarged functional vessels, decreased necrotic areas, and increased vascular endothelial growth factor (VEGF) protein levels. Galectin-3-nonexpressing-cells injected into WT and KO showed increased levels of transforming growth factor beta 1 (TGFβ1) and, in WT animals this feature was also accompanied by increased VEGFR2 expression and its phosphorylation. In KO animals, tumors derived from galectin-3-expressing cells were infiltrated by CD68(+)-cells, whereas in tumors derived from galectin-3-nonexpressing-cells, CD68(+) cells failed to infiltrate tumors and accumulated in the periphery of the tumor mass. In vitro studies showed that Tm1G3 secreted more VEGF than Tm1N3 cells. In the latter case, TGFβ1 induced VEGF production. Basal secretion of VEGF was higher in WT-bone marrow-derived macrophages (BMDM) than in KO-BMDM. TGFβ1 induced secretion of VEGF only in WT-BMDM. Tm1G3-induced tumors had the Arginase I mRNA increased, which upregulated alternative macrophage (M2)/TAM induction. M2 stimuli, such as interleukin-4 (IL4) and TGFβ1, increased Arginase I protein levels and galectin-3 expression in WT- BMDM, but not in cells from KO mice. Hence, we report that galectin-3 disruption in tumor stroma and parenchyma decreases angiogenesis through interfering with the responses of macrophages to the interdependent VEGF and TGFβ1 signaling pathways.

Original languageEnglish (US)
Pages (from-to)201-214
Number of pages14
JournalCancer Medicine
Volume3
Issue number2
DOIs
StatePublished - Apr 1 2014
Externally publishedYes

Fingerprint

Galectin 3
Transforming Growth Factor beta
Vascular Endothelial Growth Factor A
Macrophages
Neoplasms
Arginase
Proteins
Wild Animals
Tumor Burden
Knockout Mice
Interleukin-4
Melanoma
Phosphorylation

Keywords

  • Angiogenesis
  • galectin-3
  • melanoma
  • tumor microenvironment

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Machado, C. M. A. L., Andrade, L. N. O. S., Teixeira, V. R., Costa, F. F., Melo, C. M. O., dos Santos, S. N. A., ... Chammas, R. (2014). Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. Cancer Medicine, 3(2), 201-214. https://doi.org/10.1002/cam4.173

Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. / Machado, Camila M aria Longo; Andrade, Luciana N ogueira Sousa; Teixeira, Verônica Rodrigues; Costa, Fabrício Falconi; Melo, Camila M orais; dos Santos, Sofia N ascimento; Nonogaki, Suely; Liu, Fu-Tong; Bernardes, Emerson S oares; Camargo, Anamaria A ranha; Chammas, Roger.

In: Cancer Medicine, Vol. 3, No. 2, 01.04.2014, p. 201-214.

Research output: Contribution to journalArticle

Machado, CMAL, Andrade, LNOS, Teixeira, VR, Costa, FF, Melo, CMO, dos Santos, SNA, Nonogaki, S, Liu, F-T, Bernardes, ESO, Camargo, AAR & Chammas, R 2014, 'Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages', Cancer Medicine, vol. 3, no. 2, pp. 201-214. https://doi.org/10.1002/cam4.173
Machado CMAL, Andrade LNOS, Teixeira VR, Costa FF, Melo CMO, dos Santos SNA et al. Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. Cancer Medicine. 2014 Apr 1;3(2):201-214. https://doi.org/10.1002/cam4.173
Machado, Camila M aria Longo ; Andrade, Luciana N ogueira Sousa ; Teixeira, Verônica Rodrigues ; Costa, Fabrício Falconi ; Melo, Camila M orais ; dos Santos, Sofia N ascimento ; Nonogaki, Suely ; Liu, Fu-Tong ; Bernardes, Emerson S oares ; Camargo, Anamaria A ranha ; Chammas, Roger. / Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages. In: Cancer Medicine. 2014 ; Vol. 3, No. 2. pp. 201-214.
@article{eb9a56dcb211445797c01b3c11ee6da2,
title = "Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages",
abstract = "In order to study the role of galectin-3 in tumor angiogenesis associated with tumor-associated macrophages (TAM) and tumor parenchyma, the galectin-3 expression was reconstituted in Tm1 melanoma cell line that lacks this protein. Galectin-3-expressing cells (Tm1G3) and mock-vector transfected cells (Tm1N3) were injected into wild-type (WT) and galectin-3 knockout (KO) C57Bl/6 mice. Tumors originated from Tm1G3 were larger in tumor volume with enlarged functional vessels, decreased necrotic areas, and increased vascular endothelial growth factor (VEGF) protein levels. Galectin-3-nonexpressing-cells injected into WT and KO showed increased levels of transforming growth factor beta 1 (TGFβ1) and, in WT animals this feature was also accompanied by increased VEGFR2 expression and its phosphorylation. In KO animals, tumors derived from galectin-3-expressing cells were infiltrated by CD68(+)-cells, whereas in tumors derived from galectin-3-nonexpressing-cells, CD68(+) cells failed to infiltrate tumors and accumulated in the periphery of the tumor mass. In vitro studies showed that Tm1G3 secreted more VEGF than Tm1N3 cells. In the latter case, TGFβ1 induced VEGF production. Basal secretion of VEGF was higher in WT-bone marrow-derived macrophages (BMDM) than in KO-BMDM. TGFβ1 induced secretion of VEGF only in WT-BMDM. Tm1G3-induced tumors had the Arginase I mRNA increased, which upregulated alternative macrophage (M2)/TAM induction. M2 stimuli, such as interleukin-4 (IL4) and TGFβ1, increased Arginase I protein levels and galectin-3 expression in WT- BMDM, but not in cells from KO mice. Hence, we report that galectin-3 disruption in tumor stroma and parenchyma decreases angiogenesis through interfering with the responses of macrophages to the interdependent VEGF and TGFβ1 signaling pathways.",
keywords = "Angiogenesis, galectin-3, melanoma, tumor microenvironment",
author = "Machado, {Camila M aria Longo} and Andrade, {Luciana N ogueira Sousa} and Teixeira, {Ver{\^o}nica Rodrigues} and Costa, {Fabr{\'i}cio Falconi} and Melo, {Camila M orais} and {dos Santos}, {Sofia N ascimento} and Suely Nonogaki and Fu-Tong Liu and Bernardes, {Emerson S oares} and Camargo, {Anamaria A ranha} and Roger Chammas",
year = "2014",
month = "4",
day = "1",
doi = "10.1002/cam4.173",
language = "English (US)",
volume = "3",
pages = "201--214",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages

AU - Machado, Camila M aria Longo

AU - Andrade, Luciana N ogueira Sousa

AU - Teixeira, Verônica Rodrigues

AU - Costa, Fabrício Falconi

AU - Melo, Camila M orais

AU - dos Santos, Sofia N ascimento

AU - Nonogaki, Suely

AU - Liu, Fu-Tong

AU - Bernardes, Emerson S oares

AU - Camargo, Anamaria A ranha

AU - Chammas, Roger

PY - 2014/4/1

Y1 - 2014/4/1

N2 - In order to study the role of galectin-3 in tumor angiogenesis associated with tumor-associated macrophages (TAM) and tumor parenchyma, the galectin-3 expression was reconstituted in Tm1 melanoma cell line that lacks this protein. Galectin-3-expressing cells (Tm1G3) and mock-vector transfected cells (Tm1N3) were injected into wild-type (WT) and galectin-3 knockout (KO) C57Bl/6 mice. Tumors originated from Tm1G3 were larger in tumor volume with enlarged functional vessels, decreased necrotic areas, and increased vascular endothelial growth factor (VEGF) protein levels. Galectin-3-nonexpressing-cells injected into WT and KO showed increased levels of transforming growth factor beta 1 (TGFβ1) and, in WT animals this feature was also accompanied by increased VEGFR2 expression and its phosphorylation. In KO animals, tumors derived from galectin-3-expressing cells were infiltrated by CD68(+)-cells, whereas in tumors derived from galectin-3-nonexpressing-cells, CD68(+) cells failed to infiltrate tumors and accumulated in the periphery of the tumor mass. In vitro studies showed that Tm1G3 secreted more VEGF than Tm1N3 cells. In the latter case, TGFβ1 induced VEGF production. Basal secretion of VEGF was higher in WT-bone marrow-derived macrophages (BMDM) than in KO-BMDM. TGFβ1 induced secretion of VEGF only in WT-BMDM. Tm1G3-induced tumors had the Arginase I mRNA increased, which upregulated alternative macrophage (M2)/TAM induction. M2 stimuli, such as interleukin-4 (IL4) and TGFβ1, increased Arginase I protein levels and galectin-3 expression in WT- BMDM, but not in cells from KO mice. Hence, we report that galectin-3 disruption in tumor stroma and parenchyma decreases angiogenesis through interfering with the responses of macrophages to the interdependent VEGF and TGFβ1 signaling pathways.

AB - In order to study the role of galectin-3 in tumor angiogenesis associated with tumor-associated macrophages (TAM) and tumor parenchyma, the galectin-3 expression was reconstituted in Tm1 melanoma cell line that lacks this protein. Galectin-3-expressing cells (Tm1G3) and mock-vector transfected cells (Tm1N3) were injected into wild-type (WT) and galectin-3 knockout (KO) C57Bl/6 mice. Tumors originated from Tm1G3 were larger in tumor volume with enlarged functional vessels, decreased necrotic areas, and increased vascular endothelial growth factor (VEGF) protein levels. Galectin-3-nonexpressing-cells injected into WT and KO showed increased levels of transforming growth factor beta 1 (TGFβ1) and, in WT animals this feature was also accompanied by increased VEGFR2 expression and its phosphorylation. In KO animals, tumors derived from galectin-3-expressing cells were infiltrated by CD68(+)-cells, whereas in tumors derived from galectin-3-nonexpressing-cells, CD68(+) cells failed to infiltrate tumors and accumulated in the periphery of the tumor mass. In vitro studies showed that Tm1G3 secreted more VEGF than Tm1N3 cells. In the latter case, TGFβ1 induced VEGF production. Basal secretion of VEGF was higher in WT-bone marrow-derived macrophages (BMDM) than in KO-BMDM. TGFβ1 induced secretion of VEGF only in WT-BMDM. Tm1G3-induced tumors had the Arginase I mRNA increased, which upregulated alternative macrophage (M2)/TAM induction. M2 stimuli, such as interleukin-4 (IL4) and TGFβ1, increased Arginase I protein levels and galectin-3 expression in WT- BMDM, but not in cells from KO mice. Hence, we report that galectin-3 disruption in tumor stroma and parenchyma decreases angiogenesis through interfering with the responses of macrophages to the interdependent VEGF and TGFβ1 signaling pathways.

KW - Angiogenesis

KW - galectin-3

KW - melanoma

KW - tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84904610688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904610688&partnerID=8YFLogxK

U2 - 10.1002/cam4.173

DO - 10.1002/cam4.173

M3 - Article

C2 - 24421272

AN - SCOPUS:84904610688

VL - 3

SP - 201

EP - 214

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 2

ER -